Docket #: S93-077
A Novel Protein and Gene Expressed by Human T Cells and Monocytes: Alloreaction-Associated Antigen (ARAg)
Alloreaction-associated antigen (ARAg) is a novel member of the immunoglobulin superfamily. This invention's issued US patent claims composition of matter of ARAg polypeptides and nucleic acids encoding ARAg polypeptides.
Stanford research indicates ARAg may serve as an effector of immune response and a diagnostic antigen for antibody-based monitoring of immune disease.
Applications
- Drug Target
- Suppressing immune response using a monoclonal antibody against ARAg
- Monitoring immune diseases using MAb as a diagnostic
- Screening for ARAg receptors
U.S. Patent
U.S. Patent No. 5,646,251
Similar Technologies
-
Novel Endothelial Adhesion Molecule for Monocytes: L11-CD43 S92-045Novel Endothelial Adhesion Molecule for Monocytes: L11-CD43
-
Methods for guiding projection pursuit clustering and matching clusters over samples S16-277Methods for guiding projection pursuit clustering and matching clusters over samples
-
Mouse Anti-Human Hybridomas: 12E7, L243, L17F12, L368 S79-066Mouse Anti-Human Hybridomas: 12E7, L243, L17F12, L368